|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -99.00% |
|
0.00% | - |
| 27/10/21 | Patient Access Solutions, Inc. Introduces CAMEO | CI |
| 24/08/21 | Cara Therapeutics Shares Rise 7% on FDA Approval of Korsuva Injection | DJ |
| Market Cap | 350K 302K 277K 261K 491K 33.01M 495K 3.29M 1.28M 16.2M 1.31M 1.28M 56.05M | P/E 2007 * |
-
| P/E 2008 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 1.39M 1.2M 1.1M 1.03M 1.94M 131M 1.96M 13.02M 5.07M 64.17M 5.2M 5.09M 222M | EV / Sales 2007 * |
-
| EV / Sales 2008 | 24.4x |
| Free-Float |
-
| Yield 2007 * |
-
| Yield 2008 | - |
| 1 day | -99.00% |
| 1 month | 0 | 0 | |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0 | |
| 5 years | 0 | 0.01 | |
| 10 years | 0 | 0.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bruce Weitzberg
CEO | Chief Executive Officer | 66 | - |
Robert Linzalone
PRN | Corporate Officer/Principal | 66 | 02/02/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-15 | Other | 0 | 0% | |||
| 04-15 | Other | 0 | 0% | |||
| 04-15 | Other | 0 | 0% |
| 2007 | 2008 | |
|---|---|---|
| Net sales | 323K 278K 256K 241K 453K 30.45M 456K 3.03M 1.18M 14.94M 1.21M 1.19M 51.7M | 350K 302K 278K 262K 492K 33.07M 496K 3.29M 1.28M 16.23M 1.32M 1.29M 56.14M |
| Net income | -685K -591K -544K -512K -961K -64.67M -969K -6.44M -2.51M -31.74M -2.57M -2.52M -110M | -9.09M -7.84M -7.21M -6.79M -12.75M -858M -12.86M -85.44M -33.26M -421M -34.12M -33.39M -1.46B |
| Net Debt | 1.27M 1.1M 1.01M 951K 1.79M 120M 1.8M 11.97M 4.66M 59M 4.78M 4.68M 204M | 1.04M 893K 821K 773K 1.45M 97.74M 1.47M 9.73M 3.79M 47.97M 3.89M 3.8M 166M |
Employees
5
Sector
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/06/26 | 0.000001 $ | -99.00% | 156 |
- Stock Market
- Stocks
- PASO Stock
Select your edition
All financial news and data tailored to specific country editions
















